Teresa Brophy Bair
General Counsel at Kura Oncology, Inc. (KURA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $701K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | KURAKura Oncology, Inc. | Sell Plan | 8,442187,002 held (−4%) | $10.50 | $89K | +1.0% |
| Aug 21SEC | KURAKura Oncology, Inc. | Sell Plan | 31,487195,444 held (−14%) | $12.63 | $398K | -16.1% |
| May 20SEC | KURAKura Oncology, Inc. | Sell Plan | 2,256226,931 held (−1%) | $9.38 | $21K | +13.0% |
| Jan 27SEC | KURAKura Oncology, Inc. | Sell | 4,096234,043 held (−2%) | $8.46 | $35K | +25.3% |
| Jan 27SEC | KURAKura Oncology, Inc. | Sell | 2,335231,708 held (−1%) | $8.46 | $20K | +25.3% |
| Jan 27SEC | KURAKura Oncology, Inc. | Sell | 4,777226,931 held (−2%) | $8.46 | $40K | +25.3% |
| Nov 14SEC | KURAKura Oncology, Inc. | Sell Plan | 8,804188,139 held (−4%) | $11.18 | $98K | -5.2% |
- Sell
General Counsel Teresa Brophy Bair sold $89K of KURA at $10.50 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Teresa Brophy Bair sold $398K of KURA at $12.63 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Teresa Brophy Bair sold $21K of KURA at $9.38 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Teresa Brophy Bair sold $98K of KURA at $11.18 — pre-scheduled 10b5-1 plan sale.